Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 15, 2012 (Vol. 32, No. 8)

Policy Makers Seek to Fortify Superbug Research

  • With antibiotic-resistant superbugs seemingly uniting public health groups around developing new antibiotic drugs, FDA signaled last week that it got the message and will respond soon. While FDA offered few details, Commissioner Margaret A. Hamburg, M.D., and Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.